AI Article Synopsis
- D-Allulose is a rare sugar with almost no calories and potential health benefits, including lowering blood glucose levels after meals and promoting anti-aging effects.
- A systematic review and meta-analysis investigated how D-Allulose impacts blood glucose levels in healthy individuals after eating, comparing results from several studies.
- The findings revealed that consuming 5g and 10g of D-Allulose significantly decreased post-meal blood glucose levels, suggesting it could be a useful tool for blood sugar management in both healthy individuals and those at risk for diabetes.
Article Abstract
D-Allulose is a rare sugar that exists in nature. It is a food ingredient with nearly zero calories (<0.4 kcal/g) and has many physiological functionalities such as attenuation of postprandial blood glucose levels, attenuation of postprandial fat mass accumulation, and anti-aging property. This study focused on the postprandial blood glucose changes in healthy humans by a systematic review and meta-analysis. They were chosen because of its importance to a prevention from diabetes. The study objective was to examine acute blood glucose concentrations of healthy humans after the meal with and without allulose. The study collected all D-allulose related studies from various databases. A forest plot of the comparison between an allulose intake group and the control group showed both 5g and 10g intake groups have the significantly smaller area under the curve of postprandial blood glucose levels. It means that D-Allulose attenuates postprandial blood glucose concentrations in healthy humans. As the result, D-Allulose is a valuable blood glucose management tool for healthy humans and diabetes patients. Allulose Diet enables reduction of sucrose intake through Sugar Reformulation in the future diet.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079081 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0281150 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
The Effect of Allulose on the Attenuation of Glucose Release from Rice in a Static In Vitro Digestion Model.
Foods
July 2024
School of Nutrition, Toronto Metropolitan University, Toronto, ON M5B 2K3, Canada.
Allulose is a rare sugar that provides <10% of the energy but 70% of the sweetness of sucrose. Allulose has been shown to attenuate glycemic responses to carbohydrate-containing foods in vivo. This study aimed to determine the optimal allulose dose for minimizing in vitro glucose release from rice compared to a rice control and fructose.
View Article and Find Full Text PDFAllulose for the attenuation of postprandial blood glucose levels in healthy humans: A systematic review and meta-analysis.
PLoS One
April 2023
Faculty of Agriculture, Kagawa University, Kita-gun, Japan.
Article Synopsis
- D-Allulose is a rare sugar with almost no calories and potential health benefits, including lowering blood glucose levels after meals and promoting anti-aging effects.
- A systematic review and meta-analysis investigated how D-Allulose impacts blood glucose levels in healthy individuals after eating, comparing results from several studies.
- The findings revealed that consuming 5g and 10g of D-Allulose significantly decreased post-meal blood glucose levels, suggesting it could be a useful tool for blood sugar management in both healthy individuals and those at risk for diabetes.
Enhancing endogenous levels of GLP1 dampens acute olanzapine induced perturbations in lipid and glucose metabolism.
Front Pharmacol
March 2023
School of Kinesiology, University of British Columbia, Vancouver, BC, Canada.
Olanzapine is a second-generation antipsychotic (SGA) used in the treatment of schizophrenia and several on- and off-label conditions. While effective in reducing psychoses, acute olanzapine treatment causes rapid hyperglycemia, insulin resistance, and dyslipidemia and these perturbations are linked to an increased risk of developing cardiometabolic disease. Pharmacological agonists of the glucagon-like peptide-1 (GLP1) receptor have been shown to offset weight-gain associated with chronic SGA administration and mitigate the acute metabolic side effects of SGAs.
View Article and Find Full Text PDFd-Allulose Supplementation Prevents Diet-Induced Hepatic Lipid Accumulation via miR-130-Mediated Regulation in C57BL/6 Mice.
Mol Nutr Food Res
February 2023
Department of Physiology 2, Kawasaki Medical School, Kurashiki, 701-0192, Japan.
Scope: d-allulose is a low-calorie rare sugar. It has been reported that d-allulose supplementation significantly inhibits diet-induced hepatic fat accumulation. However, the underlying molecular mechanisms remain unclear.
View Article and Find Full Text PDFd-allulose protects against diabetic nephropathy progression in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes.
PLoS One
February 2022
Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University, Miki, Kagawa, Japan.
Article Synopsis
- d-allulose is a rare sugar that shows promise in reducing high blood sugar and delaying diabetic nephropathy progression in type 2 diabetes models.
- The study involved giving OLETF rats water with or without 3% d-allulose for 13 weeks and showed significant improvements in blood glucose levels and kidney health.
- The findings suggest that d-allulose may lower inflammation and prevent kidney damage, but further research is needed to fully understand its effects on renal inflammation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!